nodes	percent_of_prediction	percent_of_DWPC	metapath
Diflunisal—PTGS2—Risedronate—osteoporosis	0.339	0.515	CbGbCtD
Diflunisal—ALB—Estropipate—osteoporosis	0.162	0.246	CbGbCtD
Diflunisal—SLC22A6—Conjugated Estrogens—osteoporosis	0.0899	0.137	CbGbCtD
Diflunisal—ALB—Estradiol—osteoporosis	0.0672	0.102	CbGbCtD
Diflunisal—Loss of consciousness—Pamidronate—osteoporosis	0.000568	0.00211	CcSEcCtD
Diflunisal—Muscle spasms—Zoledronate—osteoporosis	0.000568	0.00211	CcSEcCtD
Diflunisal—Jaundice—Estradiol—osteoporosis	0.000567	0.00211	CcSEcCtD
Diflunisal—Gastrointestinal pain—Alendronate—osteoporosis	0.000565	0.0021	CcSEcCtD
Diflunisal—Constipation—Calcitriol—osteoporosis	0.000564	0.0021	CcSEcCtD
Diflunisal—Flatulence—Conjugated Estrogens—osteoporosis	0.00056	0.00208	CcSEcCtD
Diflunisal—Tension—Conjugated Estrogens—osteoporosis	0.000558	0.00208	CcSEcCtD
Diflunisal—Urticaria—Estropipate—osteoporosis	0.000558	0.00208	CcSEcCtD
Diflunisal—Vision blurred—Zoledronate—osteoporosis	0.000556	0.00207	CcSEcCtD
Diflunisal—Gastrointestinal pain—Raloxifene—osteoporosis	0.000556	0.00207	CcSEcCtD
Diflunisal—Diarrhoea—Etidronic acid—osteoporosis	0.000555	0.00207	CcSEcCtD
Diflunisal—Haematuria—Estradiol—osteoporosis	0.000555	0.00207	CcSEcCtD
Diflunisal—Body temperature increased—Estropipate—osteoporosis	0.000555	0.00207	CcSEcCtD
Diflunisal—Feeling abnormal—Ibandronate—osteoporosis	0.000555	0.00206	CcSEcCtD
Diflunisal—Nervousness—Conjugated Estrogens—osteoporosis	0.000552	0.00205	CcSEcCtD
Diflunisal—Gastrointestinal pain—Ibandronate—osteoporosis	0.000551	0.00205	CcSEcCtD
Diflunisal—Urticaria—Alendronate—osteoporosis	0.000549	0.00204	CcSEcCtD
Diflunisal—Body temperature increased—Alendronate—osteoporosis	0.000547	0.00203	CcSEcCtD
Diflunisal—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000547	0.00203	CcSEcCtD
Diflunisal—Shock—Risedronate—osteoporosis	0.000546	0.00203	CcSEcCtD
Diflunisal—Angioedema—Zoledronate—osteoporosis	0.000539	0.00201	CcSEcCtD
Diflunisal—Gastrointestinal pain—Calcitriol—osteoporosis	0.000539	0.00201	CcSEcCtD
Diflunisal—Body temperature increased—Raloxifene—osteoporosis	0.000538	0.002	CcSEcCtD
Diflunisal—Vision blurred—Conjugated Estrogens—osteoporosis	0.000536	0.00199	CcSEcCtD
Diflunisal—Urticaria—Ibandronate—osteoporosis	0.000535	0.00199	CcSEcCtD
Diflunisal—Body temperature increased—Ibandronate—osteoporosis	0.000532	0.00198	CcSEcCtD
Diflunisal—Confusional state—Pamidronate—osteoporosis	0.000532	0.00198	CcSEcCtD
Diflunisal—Vertigo—Zoledronate—osteoporosis	0.00053	0.00197	CcSEcCtD
Diflunisal—Syncope—Zoledronate—osteoporosis	0.000529	0.00197	CcSEcCtD
Diflunisal—Anaphylactic shock—Pamidronate—osteoporosis	0.000527	0.00196	CcSEcCtD
Diflunisal—Oedema—Pamidronate—osteoporosis	0.000527	0.00196	CcSEcCtD
Diflunisal—Urticaria—Calcitriol—osteoporosis	0.000524	0.00195	CcSEcCtD
Diflunisal—Hepatitis—Estradiol—osteoporosis	0.000523	0.00195	CcSEcCtD
Diflunisal—Palpitations—Zoledronate—osteoporosis	0.000522	0.00194	CcSEcCtD
Diflunisal—Body temperature increased—Calcitriol—osteoporosis	0.000521	0.00194	CcSEcCtD
Diflunisal—Angioedema—Conjugated Estrogens—osteoporosis	0.000519	0.00193	CcSEcCtD
Diflunisal—Shock—Pamidronate—osteoporosis	0.000519	0.00193	CcSEcCtD
Diflunisal—Loss of consciousness—Zoledronate—osteoporosis	0.000519	0.00193	CcSEcCtD
Diflunisal—Hypersensitivity—Estropipate—osteoporosis	0.000517	0.00193	CcSEcCtD
Diflunisal—Thrombocytopenia—Pamidronate—osteoporosis	0.000516	0.00192	CcSEcCtD
Diflunisal—Vomiting—Etidronic acid—osteoporosis	0.000516	0.00192	CcSEcCtD
Diflunisal—Rash—Etidronic acid—osteoporosis	0.000512	0.0019	CcSEcCtD
Diflunisal—Dermatitis—Etidronic acid—osteoporosis	0.000511	0.0019	CcSEcCtD
Diflunisal—Vertigo—Conjugated Estrogens—osteoporosis	0.000511	0.0019	CcSEcCtD
Diflunisal—Hyperhidrosis—Pamidronate—osteoporosis	0.00051	0.0019	CcSEcCtD
Diflunisal—Syncope—Conjugated Estrogens—osteoporosis	0.00051	0.0019	CcSEcCtD
Diflunisal—Hypersensitivity—Alendronate—osteoporosis	0.000509	0.0019	CcSEcCtD
Diflunisal—Headache—Etidronic acid—osteoporosis	0.000508	0.00189	CcSEcCtD
Diflunisal—Asthenia—Estropipate—osteoporosis	0.000504	0.00187	CcSEcCtD
Diflunisal—Visual impairment—Estradiol—osteoporosis	0.000504	0.00187	CcSEcCtD
Diflunisal—Anorexia—Pamidronate—osteoporosis	0.000503	0.00187	CcSEcCtD
Diflunisal—Chest pain—Zoledronate—osteoporosis	0.000503	0.00187	CcSEcCtD
Diflunisal—Palpitations—Conjugated Estrogens—osteoporosis	0.000502	0.00187	CcSEcCtD
Diflunisal—Insomnia—Risedronate—osteoporosis	0.000502	0.00187	CcSEcCtD
Diflunisal—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.0005	0.00186	CcSEcCtD
Diflunisal—Paraesthesia—Risedronate—osteoporosis	0.000498	0.00185	CcSEcCtD
Diflunisal—Pruritus—Estropipate—osteoporosis	0.000497	0.00185	CcSEcCtD
Diflunisal—Asthenia—Alendronate—osteoporosis	0.000496	0.00185	CcSEcCtD
Diflunisal—Hypersensitivity—Ibandronate—osteoporosis	0.000496	0.00185	CcSEcCtD
Diflunisal—Dyspnoea—Risedronate—osteoporosis	0.000495	0.00184	CcSEcCtD
Diflunisal—Erythema multiforme—Estradiol—osteoporosis	0.000494	0.00184	CcSEcCtD
Diflunisal—Fatigue—Ethinyl Estradiol—osteoporosis	0.000491	0.00183	CcSEcCtD
Diflunisal—Pruritus—Alendronate—osteoporosis	0.000489	0.00182	CcSEcCtD
Diflunisal—Dyspepsia—Risedronate—osteoporosis	0.000488	0.00182	CcSEcCtD
Diflunisal—Tinnitus—Estradiol—osteoporosis	0.000487	0.00181	CcSEcCtD
Diflunisal—Constipation—Ethinyl Estradiol—osteoporosis	0.000487	0.00181	CcSEcCtD
Diflunisal—Confusional state—Zoledronate—osteoporosis	0.000486	0.00181	CcSEcCtD
Diflunisal—Hypersensitivity—Calcitriol—osteoporosis	0.000486	0.00181	CcSEcCtD
Diflunisal—Flushing—Estradiol—osteoporosis	0.000485	0.00181	CcSEcCtD
Diflunisal—Chest pain—Conjugated Estrogens—osteoporosis	0.000484	0.0018	CcSEcCtD
Diflunisal—Asthenia—Ibandronate—osteoporosis	0.000483	0.0018	CcSEcCtD
Diflunisal—Nausea—Etidronic acid—osteoporosis	0.000482	0.00179	CcSEcCtD
Diflunisal—Oedema—Zoledronate—osteoporosis	0.000482	0.00179	CcSEcCtD
Diflunisal—Anaphylactic shock—Zoledronate—osteoporosis	0.000482	0.00179	CcSEcCtD
Diflunisal—Diarrhoea—Estropipate—osteoporosis	0.00048	0.00179	CcSEcCtD
Diflunisal—Fatigue—Risedronate—osteoporosis	0.000478	0.00178	CcSEcCtD
Diflunisal—Insomnia—Pamidronate—osteoporosis	0.000477	0.00178	CcSEcCtD
Diflunisal—Pruritus—Ibandronate—osteoporosis	0.000476	0.00177	CcSEcCtD
Diflunisal—Constipation—Risedronate—osteoporosis	0.000474	0.00177	CcSEcCtD
Diflunisal—Shock—Zoledronate—osteoporosis	0.000474	0.00176	CcSEcCtD
Diflunisal—Paraesthesia—Pamidronate—osteoporosis	0.000474	0.00176	CcSEcCtD
Diflunisal—Diarrhoea—Alendronate—osteoporosis	0.000473	0.00176	CcSEcCtD
Diflunisal—Asthenia—Calcitriol—osteoporosis	0.000473	0.00176	CcSEcCtD
Diflunisal—Thrombocytopenia—Zoledronate—osteoporosis	0.000472	0.00176	CcSEcCtD
Diflunisal—Dyspnoea—Pamidronate—osteoporosis	0.00047	0.00175	CcSEcCtD
Diflunisal—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000469	0.00175	CcSEcCtD
Diflunisal—Somnolence—Pamidronate—osteoporosis	0.000469	0.00175	CcSEcCtD
Diflunisal—Pruritus—Calcitriol—osteoporosis	0.000466	0.00174	CcSEcCtD
Diflunisal—Hyperhidrosis—Zoledronate—osteoporosis	0.000466	0.00173	CcSEcCtD
Diflunisal—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000465	0.00173	CcSEcCtD
Diflunisal—Diarrhoea—Raloxifene—osteoporosis	0.000465	0.00173	CcSEcCtD
Diflunisal—Dyspepsia—Pamidronate—osteoporosis	0.000464	0.00173	CcSEcCtD
Diflunisal—Dizziness—Estropipate—osteoporosis	0.000464	0.00173	CcSEcCtD
Diflunisal—Oedema—Conjugated Estrogens—osteoporosis	0.000464	0.00173	CcSEcCtD
Diflunisal—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000464	0.00173	CcSEcCtD
Diflunisal—Diarrhoea—Ibandronate—osteoporosis	0.000461	0.00171	CcSEcCtD
Diflunisal—Anorexia—Zoledronate—osteoporosis	0.000459	0.00171	CcSEcCtD
Diflunisal—Decreased appetite—Pamidronate—osteoporosis	0.000459	0.00171	CcSEcCtD
Diflunisal—Dizziness—Alendronate—osteoporosis	0.000457	0.0017	CcSEcCtD
Diflunisal—Shock—Conjugated Estrogens—osteoporosis	0.000456	0.0017	CcSEcCtD
Diflunisal—Fatigue—Pamidronate—osteoporosis	0.000455	0.00169	CcSEcCtD
Diflunisal—Gastrointestinal pain—Risedronate—osteoporosis	0.000454	0.00169	CcSEcCtD
Diflunisal—Urticaria—Ethinyl Estradiol—osteoporosis	0.000452	0.00168	CcSEcCtD
Diflunisal—Constipation—Pamidronate—osteoporosis	0.000451	0.00168	CcSEcCtD
Diflunisal—Diarrhoea—Calcitriol—osteoporosis	0.000451	0.00168	CcSEcCtD
Diflunisal—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00045	0.00167	CcSEcCtD
Diflunisal—Dizziness—Raloxifene—osteoporosis	0.00045	0.00167	CcSEcCtD
Diflunisal—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000448	0.00167	CcSEcCtD
Diflunisal—Flatulence—Estradiol—osteoporosis	0.000448	0.00167	CcSEcCtD
Diflunisal—Tension—Estradiol—osteoporosis	0.000446	0.00166	CcSEcCtD
Diflunisal—Vomiting—Estropipate—osteoporosis	0.000446	0.00166	CcSEcCtD
Diflunisal—Dizziness—Ibandronate—osteoporosis	0.000445	0.00166	CcSEcCtD
Diflunisal—Rash—Estropipate—osteoporosis	0.000443	0.00165	CcSEcCtD
Diflunisal—Dermatitis—Estropipate—osteoporosis	0.000442	0.00165	CcSEcCtD
Diflunisal—Anorexia—Conjugated Estrogens—osteoporosis	0.000442	0.00165	CcSEcCtD
Diflunisal—Nervousness—Estradiol—osteoporosis	0.000442	0.00164	CcSEcCtD
Diflunisal—Urticaria—Risedronate—osteoporosis	0.000441	0.00164	CcSEcCtD
Diflunisal—Headache—Estropipate—osteoporosis	0.00044	0.00164	CcSEcCtD
Diflunisal—Vomiting—Alendronate—osteoporosis	0.00044	0.00164	CcSEcCtD
Diflunisal—Body temperature increased—Risedronate—osteoporosis	0.000439	0.00163	CcSEcCtD
Diflunisal—Muscle spasms—Estradiol—osteoporosis	0.000437	0.00163	CcSEcCtD
Diflunisal—Rash—Alendronate—osteoporosis	0.000436	0.00162	CcSEcCtD
Diflunisal—Insomnia—Zoledronate—osteoporosis	0.000436	0.00162	CcSEcCtD
Diflunisal—Dermatitis—Alendronate—osteoporosis	0.000436	0.00162	CcSEcCtD
Diflunisal—Feeling abnormal—Pamidronate—osteoporosis	0.000435	0.00162	CcSEcCtD
Diflunisal—Headache—Alendronate—osteoporosis	0.000433	0.00161	CcSEcCtD
Diflunisal—Paraesthesia—Zoledronate—osteoporosis	0.000433	0.00161	CcSEcCtD
Diflunisal—Vomiting—Raloxifene—osteoporosis	0.000432	0.00161	CcSEcCtD
Diflunisal—Gastrointestinal pain—Pamidronate—osteoporosis	0.000431	0.00161	CcSEcCtD
Diflunisal—Dyspnoea—Zoledronate—osteoporosis	0.00043	0.0016	CcSEcCtD
Diflunisal—Rash—Raloxifene—osteoporosis	0.000429	0.0016	CcSEcCtD
Diflunisal—Dermatitis—Raloxifene—osteoporosis	0.000428	0.00159	CcSEcCtD
Diflunisal—Somnolence—Zoledronate—osteoporosis	0.000428	0.00159	CcSEcCtD
Diflunisal—Vomiting—Ibandronate—osteoporosis	0.000428	0.00159	CcSEcCtD
Diflunisal—Headache—Raloxifene—osteoporosis	0.000426	0.00159	CcSEcCtD
Diflunisal—Rash—Ibandronate—osteoporosis	0.000425	0.00158	CcSEcCtD
Diflunisal—Dermatitis—Ibandronate—osteoporosis	0.000424	0.00158	CcSEcCtD
Diflunisal—Dyspepsia—Zoledronate—osteoporosis	0.000424	0.00158	CcSEcCtD
Diflunisal—Headache—Ibandronate—osteoporosis	0.000422	0.00157	CcSEcCtD
Diflunisal—Insomnia—Conjugated Estrogens—osteoporosis	0.00042	0.00156	CcSEcCtD
Diflunisal—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000419	0.00156	CcSEcCtD
Diflunisal—Vomiting—Calcitriol—osteoporosis	0.000419	0.00156	CcSEcCtD
Diflunisal—Decreased appetite—Zoledronate—osteoporosis	0.000419	0.00156	CcSEcCtD
Diflunisal—Nausea—Estropipate—osteoporosis	0.000417	0.00155	CcSEcCtD
Diflunisal—Body temperature increased—Pamidronate—osteoporosis	0.000417	0.00155	CcSEcCtD
Diflunisal—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000417	0.00155	CcSEcCtD
Diflunisal—Angioedema—Estradiol—osteoporosis	0.000416	0.00155	CcSEcCtD
Diflunisal—Rash—Calcitriol—osteoporosis	0.000416	0.00155	CcSEcCtD
Diflunisal—Fatigue—Zoledronate—osteoporosis	0.000415	0.00155	CcSEcCtD
Diflunisal—Dermatitis—Calcitriol—osteoporosis	0.000415	0.00155	CcSEcCtD
Diflunisal—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000414	0.00154	CcSEcCtD
Diflunisal—Headache—Calcitriol—osteoporosis	0.000413	0.00154	CcSEcCtD
Diflunisal—Somnolence—Conjugated Estrogens—osteoporosis	0.000412	0.00154	CcSEcCtD
Diflunisal—Constipation—Zoledronate—osteoporosis	0.000412	0.00153	CcSEcCtD
Diflunisal—Nausea—Alendronate—osteoporosis	0.000411	0.00153	CcSEcCtD
Diflunisal—Hypersensitivity—Risedronate—osteoporosis	0.000409	0.00152	CcSEcCtD
Diflunisal—Vertigo—Estradiol—osteoporosis	0.000409	0.00152	CcSEcCtD
Diflunisal—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000408	0.00152	CcSEcCtD
Diflunisal—Asthenia—Ethinyl Estradiol—osteoporosis	0.000408	0.00152	CcSEcCtD
Diflunisal—Syncope—Estradiol—osteoporosis	0.000408	0.00152	CcSEcCtD
Diflunisal—Nausea—Raloxifene—osteoporosis	0.000404	0.0015	CcSEcCtD
Diflunisal—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000403	0.0015	CcSEcCtD
Diflunisal—Pruritus—Ethinyl Estradiol—osteoporosis	0.000403	0.0015	CcSEcCtD
Diflunisal—Palpitations—Estradiol—osteoporosis	0.000402	0.0015	CcSEcCtD
Diflunisal—Fatigue—Conjugated Estrogens—osteoporosis	0.0004	0.00149	CcSEcCtD
Diflunisal—Nausea—Ibandronate—osteoporosis	0.0004	0.00149	CcSEcCtD
Diflunisal—Loss of consciousness—Estradiol—osteoporosis	0.0004	0.00149	CcSEcCtD
Diflunisal—Asthenia—Risedronate—osteoporosis	0.000398	0.00148	CcSEcCtD
Diflunisal—TTR—vertebral column—osteoporosis	0.000397	0.58	CbGeAlD
Diflunisal—Feeling abnormal—Zoledronate—osteoporosis	0.000397	0.00148	CcSEcCtD
Diflunisal—Constipation—Conjugated Estrogens—osteoporosis	0.000397	0.00148	CcSEcCtD
Diflunisal—Gastrointestinal pain—Zoledronate—osteoporosis	0.000394	0.00147	CcSEcCtD
Diflunisal—Pruritus—Risedronate—osteoporosis	0.000393	0.00146	CcSEcCtD
Diflunisal—Nausea—Calcitriol—osteoporosis	0.000391	0.00146	CcSEcCtD
Diflunisal—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000389	0.00145	CcSEcCtD
Diflunisal—Hypersensitivity—Pamidronate—osteoporosis	0.000389	0.00145	CcSEcCtD
Diflunisal—Chest pain—Estradiol—osteoporosis	0.000387	0.00144	CcSEcCtD
Diflunisal—Urticaria—Zoledronate—osteoporosis	0.000383	0.00142	CcSEcCtD
Diflunisal—Body temperature increased—Zoledronate—osteoporosis	0.000381	0.00142	CcSEcCtD
Diflunisal—Diarrhoea—Risedronate—osteoporosis	0.00038	0.00141	CcSEcCtD
Diflunisal—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000379	0.00141	CcSEcCtD
Diflunisal—Asthenia—Pamidronate—osteoporosis	0.000378	0.00141	CcSEcCtD
Diflunisal—Dizziness—Ethinyl Estradiol—osteoporosis	0.000376	0.0014	CcSEcCtD
Diflunisal—Confusional state—Estradiol—osteoporosis	0.000374	0.00139	CcSEcCtD
Diflunisal—Pruritus—Pamidronate—osteoporosis	0.000373	0.00139	CcSEcCtD
Diflunisal—Anaphylactic shock—Estradiol—osteoporosis	0.000371	0.00138	CcSEcCtD
Diflunisal—Oedema—Estradiol—osteoporosis	0.000371	0.00138	CcSEcCtD
Diflunisal—Urticaria—Conjugated Estrogens—osteoporosis	0.000369	0.00137	CcSEcCtD
Diflunisal—Dizziness—Risedronate—osteoporosis	0.000367	0.00137	CcSEcCtD
Diflunisal—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000367	0.00136	CcSEcCtD
Diflunisal—Shock—Estradiol—osteoporosis	0.000365	0.00136	CcSEcCtD
Diflunisal—Vomiting—Ethinyl Estradiol—osteoporosis	0.000362	0.00135	CcSEcCtD
Diflunisal—Diarrhoea—Pamidronate—osteoporosis	0.000361	0.00134	CcSEcCtD
Diflunisal—Hyperhidrosis—Estradiol—osteoporosis	0.000359	0.00134	CcSEcCtD
Diflunisal—Rash—Ethinyl Estradiol—osteoporosis	0.000359	0.00134	CcSEcCtD
Diflunisal—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000358	0.00133	CcSEcCtD
Diflunisal—Headache—Ethinyl Estradiol—osteoporosis	0.000357	0.00133	CcSEcCtD
Diflunisal—Hypersensitivity—Zoledronate—osteoporosis	0.000355	0.00132	CcSEcCtD
Diflunisal—Vomiting—Risedronate—osteoporosis	0.000353	0.00131	CcSEcCtD
Diflunisal—Rash—Risedronate—osteoporosis	0.00035	0.0013	CcSEcCtD
Diflunisal—Dermatitis—Risedronate—osteoporosis	0.00035	0.0013	CcSEcCtD
Diflunisal—Dizziness—Pamidronate—osteoporosis	0.000349	0.0013	CcSEcCtD
Diflunisal—Headache—Risedronate—osteoporosis	0.000348	0.00129	CcSEcCtD
Diflunisal—Asthenia—Zoledronate—osteoporosis	0.000346	0.00129	CcSEcCtD
Diflunisal—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000342	0.00127	CcSEcCtD
Diflunisal—Pruritus—Zoledronate—osteoporosis	0.000341	0.00127	CcSEcCtD
Diflunisal—Nausea—Ethinyl Estradiol—osteoporosis	0.000338	0.00126	CcSEcCtD
Diflunisal—Insomnia—Estradiol—osteoporosis	0.000336	0.00125	CcSEcCtD
Diflunisal—Vomiting—Pamidronate—osteoporosis	0.000335	0.00125	CcSEcCtD
Diflunisal—Paraesthesia—Estradiol—osteoporosis	0.000333	0.00124	CcSEcCtD
Diflunisal—Asthenia—Conjugated Estrogens—osteoporosis	0.000333	0.00124	CcSEcCtD
Diflunisal—Rash—Pamidronate—osteoporosis	0.000333	0.00124	CcSEcCtD
Diflunisal—Dermatitis—Pamidronate—osteoporosis	0.000332	0.00124	CcSEcCtD
Diflunisal—Dyspnoea—Estradiol—osteoporosis	0.000331	0.00123	CcSEcCtD
Diflunisal—Headache—Pamidronate—osteoporosis	0.00033	0.00123	CcSEcCtD
Diflunisal—Somnolence—Estradiol—osteoporosis	0.00033	0.00123	CcSEcCtD
Diflunisal—Diarrhoea—Zoledronate—osteoporosis	0.00033	0.00123	CcSEcCtD
Diflunisal—Nausea—Risedronate—osteoporosis	0.00033	0.00123	CcSEcCtD
Diflunisal—Pruritus—Conjugated Estrogens—osteoporosis	0.000328	0.00122	CcSEcCtD
Diflunisal—Dyspepsia—Estradiol—osteoporosis	0.000327	0.00122	CcSEcCtD
Diflunisal—Decreased appetite—Estradiol—osteoporosis	0.000323	0.0012	CcSEcCtD
Diflunisal—Fatigue—Estradiol—osteoporosis	0.00032	0.00119	CcSEcCtD
Diflunisal—Dizziness—Zoledronate—osteoporosis	0.000319	0.00119	CcSEcCtD
Diflunisal—Constipation—Estradiol—osteoporosis	0.000318	0.00118	CcSEcCtD
Diflunisal—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000317	0.00118	CcSEcCtD
Diflunisal—Nausea—Pamidronate—osteoporosis	0.000313	0.00117	CcSEcCtD
Diflunisal—Dizziness—Conjugated Estrogens—osteoporosis	0.000307	0.00114	CcSEcCtD
Diflunisal—Vomiting—Zoledronate—osteoporosis	0.000306	0.00114	CcSEcCtD
Diflunisal—Feeling abnormal—Estradiol—osteoporosis	0.000306	0.00114	CcSEcCtD
Diflunisal—Rash—Zoledronate—osteoporosis	0.000304	0.00113	CcSEcCtD
Diflunisal—Gastrointestinal pain—Estradiol—osteoporosis	0.000304	0.00113	CcSEcCtD
Diflunisal—Dermatitis—Zoledronate—osteoporosis	0.000304	0.00113	CcSEcCtD
Diflunisal—Headache—Zoledronate—osteoporosis	0.000302	0.00112	CcSEcCtD
Diflunisal—Vomiting—Conjugated Estrogens—osteoporosis	0.000295	0.0011	CcSEcCtD
Diflunisal—Urticaria—Estradiol—osteoporosis	0.000295	0.0011	CcSEcCtD
Diflunisal—Body temperature increased—Estradiol—osteoporosis	0.000294	0.00109	CcSEcCtD
Diflunisal—Rash—Conjugated Estrogens—osteoporosis	0.000293	0.00109	CcSEcCtD
Diflunisal—Dermatitis—Conjugated Estrogens—osteoporosis	0.000292	0.00109	CcSEcCtD
Diflunisal—Headache—Conjugated Estrogens—osteoporosis	0.000291	0.00108	CcSEcCtD
Diflunisal—Nausea—Zoledronate—osteoporosis	0.000286	0.00107	CcSEcCtD
Diflunisal—Nausea—Conjugated Estrogens—osteoporosis	0.000276	0.00103	CcSEcCtD
Diflunisal—Hypersensitivity—Estradiol—osteoporosis	0.000274	0.00102	CcSEcCtD
Diflunisal—Asthenia—Estradiol—osteoporosis	0.000266	0.000991	CcSEcCtD
Diflunisal—Pruritus—Estradiol—osteoporosis	0.000263	0.000978	CcSEcCtD
Diflunisal—Diarrhoea—Estradiol—osteoporosis	0.000254	0.000946	CcSEcCtD
Diflunisal—Dizziness—Estradiol—osteoporosis	0.000246	0.000914	CcSEcCtD
Diflunisal—Vomiting—Estradiol—osteoporosis	0.000236	0.000879	CcSEcCtD
Diflunisal—Rash—Estradiol—osteoporosis	0.000234	0.000871	CcSEcCtD
Diflunisal—Dermatitis—Estradiol—osteoporosis	0.000234	0.000871	CcSEcCtD
Diflunisal—Headache—Estradiol—osteoporosis	0.000233	0.000866	CcSEcCtD
Diflunisal—Nausea—Estradiol—osteoporosis	0.000221	0.000821	CcSEcCtD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000191	0.00262	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—RAP1A—osteoporosis	0.00019	0.00261	CbGpPWpGaD
Diflunisal—PTGS1—Biological oxidations—CYP19A1—osteoporosis	0.000189	0.0026	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—TLN1—osteoporosis	0.000187	0.00256	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000186	0.00255	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—VCL—osteoporosis	0.000184	0.00253	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000181	0.00249	CbGpPWpGaD
Diflunisal—TTR—Disease—TPI1—osteoporosis	0.00018	0.00247	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000178	0.00244	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—SOD2—osteoporosis	0.000177	0.00243	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MGLL—osteoporosis	0.000174	0.00239	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000173	0.00238	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—LRP5—osteoporosis	0.00017	0.00233	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—GPX1—osteoporosis	0.000169	0.00232	CbGpPWpGaD
Diflunisal—TTR—Disease—P4HB—osteoporosis	0.000169	0.00232	CbGpPWpGaD
Diflunisal—PTGS2—periosteum—osteoporosis	0.000167	0.243	CbGeAlD
Diflunisal—TTR—Disease—GAPDH—osteoporosis	0.000166	0.00228	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—LRP6—osteoporosis	0.000163	0.00223	CbGpPWpGaD
Diflunisal—TTR—Disease—NFATC1—osteoporosis	0.000158	0.00216	CbGpPWpGaD
Diflunisal—TTR—Disease—DKK1—osteoporosis	0.000156	0.00215	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—MTHFR—osteoporosis	0.000156	0.00214	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000155	0.00212	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	0.000154	0.00211	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—CAP1—osteoporosis	0.000154	0.00211	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—ENO1—osteoporosis	0.000154	0.00211	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000152	0.00209	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PSMA5—osteoporosis	0.000151	0.00208	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PSMA2—osteoporosis	0.000151	0.00208	CbGpPWpGaD
Diflunisal—TTR—Disease—WNT1—osteoporosis	0.000151	0.00207	CbGpPWpGaD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	0.00015	0.00206	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000147	0.00201	CbGpPWpGaD
Diflunisal—TTR—Disease—FGA—osteoporosis	0.000147	0.00201	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—IL1B—osteoporosis	0.000144	0.00198	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—IL1B—osteoporosis	0.000143	0.00197	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—LEP—osteoporosis	0.000142	0.00195	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000141	0.00194	CbGpPWpGaD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	0.00014	0.00192	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—FGA—osteoporosis	0.00014	0.00192	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000138	0.0019	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000137	0.00189	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TLN1—osteoporosis	0.000137	0.00188	CbGpPWpGaD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoporosis	0.000131	0.00179	CbGpPWpGaD
Diflunisal—TTR—Disease—ENO1—osteoporosis	0.000131	0.00179	CbGpPWpGaD
Diflunisal—ALB—Platelet degranulation—IGF1—osteoporosis	0.00013	0.00178	CbGpPWpGaD
Diflunisal—TTR—Disease—PSMA5—osteoporosis	0.000129	0.00177	CbGpPWpGaD
Diflunisal—TTR—Disease—PSMA2—osteoporosis	0.000129	0.00177	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—FGB—osteoporosis	0.000127	0.00174	CbGpPWpGaD
Diflunisal—TTR—Extracellular matrix organization—TGFB1—osteoporosis	0.000126	0.00173	CbGpPWpGaD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	0.000124	0.0017	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—CYP19A1—osteoporosis	0.000123	0.00168	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—MGLL—osteoporosis	0.000122	0.00168	CbGpPWpGaD
Diflunisal—TTR—Disease—CALCA—osteoporosis	0.00012	0.00165	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—P4HB—osteoporosis	0.000118	0.00162	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000118	0.00161	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—IL1B—osteoporosis	0.000117	0.0016	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PTH—osteoporosis	0.000115	0.00158	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—IL1B—osteoporosis	0.000115	0.00157	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000114	0.00157	CbGpPWpGaD
Diflunisal—PTGS1—Biological oxidations—POMC—osteoporosis	0.000114	0.00156	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—RAP1A—osteoporosis	0.000113	0.00155	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CNR2—osteoporosis	0.000112	0.00154	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—ANXA2—osteoporosis	0.000112	0.00153	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PLEK—osteoporosis	0.000112	0.00153	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000111	0.00153	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—NFATC1—osteoporosis	0.00011	0.00152	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.00011	0.00151	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—DKK1—osteoporosis	0.00011	0.0015	CbGpPWpGaD
Diflunisal—TTR—Disease—KL—osteoporosis	0.000109	0.0015	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PKM—osteoporosis	0.000107	0.00147	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—FDPS—osteoporosis	0.000107	0.00147	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—WNT1—osteoporosis	0.000106	0.00145	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—TNF—osteoporosis	0.000105	0.00144	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—TNF—osteoporosis	0.000104	0.00143	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—FGA—osteoporosis	0.000103	0.00141	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PGLS—osteoporosis	0.000102	0.0014	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GPD2—osteoporosis	0.000102	0.0014	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PKM—osteoporosis	0.000102	0.0014	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SOST—osteoporosis	0.000102	0.0014	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—ADCY5—osteoporosis	0.0001	0.00138	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—GPX1—osteoporosis	0.0001	0.00137	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—ANXA2—osteoporosis	9.67e-05	0.00133	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PGLS—osteoporosis	9.64e-05	0.00132	CbGpPWpGaD
Diflunisal—PTGS2—Disease—ANTXR2—osteoporosis	9.64e-05	0.00132	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—TLN1—osteoporosis	9.63e-05	0.00132	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PTHLH—osteoporosis	9.54e-05	0.00131	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—BMP2—osteoporosis	9.54e-05	0.00131	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—VCL—osteoporosis	9.5e-05	0.0013	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	9.34e-05	0.00128	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—FGB—osteoporosis	9.34e-05	0.00128	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ATIC—osteoporosis	9.3e-05	0.00128	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PNP—osteoporosis	9.3e-05	0.00128	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	9.27e-05	0.00127	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—MYC—osteoporosis	9.26e-05	0.00127	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	9.23e-05	0.00127	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—MTHFR—osteoporosis	9.23e-05	0.00127	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—IL1B—osteoporosis	9.06e-05	0.00124	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PSMA2—osteoporosis	9.02e-05	0.00124	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PSMA5—osteoporosis	9.02e-05	0.00124	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	8.89e-05	0.00122	CbGpPWpGaD
Diflunisal—TTR—Disease—ADCY5—osteoporosis	8.53e-05	0.00117	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—FDPS—osteoporosis	8.52e-05	0.00117	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PKM—osteoporosis	8.52e-05	0.00117	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—TNF—osteoporosis	8.47e-05	0.00116	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—IL6—osteoporosis	8.45e-05	0.00116	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CALCA—osteoporosis	8.4e-05	0.00115	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	8.4e-05	0.00115	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—TNF—osteoporosis	8.31e-05	0.00114	CbGpPWpGaD
Diflunisal—PTGS2—Disease—GSN—osteoporosis	8.2e-05	0.00113	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GPD2—osteoporosis	8.08e-05	0.00111	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PGLS—osteoporosis	8.08e-05	0.00111	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	7.99e-05	0.0011	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—RAP1A—osteoporosis	7.94e-05	0.00109	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—OXCT1—osteoporosis	7.91e-05	0.00109	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CA2—osteoporosis	7.91e-05	0.00109	CbGpPWpGaD
Diflunisal—TTR—Disease—MTHFR—osteoporosis	7.85e-05	0.00108	CbGpPWpGaD
Diflunisal—ALB—Platelet degranulation—TGFB1—osteoporosis	7.77e-05	0.00107	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—MGLL—osteoporosis	7.71e-05	0.00106	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—KL—osteoporosis	7.63e-05	0.00105	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	7.56e-05	0.00104	CbGpPWpGaD
Diflunisal—TTR—Disease—IRS2—osteoporosis	7.47e-05	0.00102	CbGpPWpGaD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	7.41e-05	0.00102	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ATIC—osteoporosis	7.39e-05	0.00101	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PNP—osteoporosis	7.39e-05	0.00101	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—POMC—osteoporosis	7.38e-05	0.00101	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	7.27e-05	0.000998	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—FGA—osteoporosis	7.2e-05	0.000988	CbGpPWpGaD
Diflunisal—PTGS2—Disease—LRP5—osteoporosis	7.13e-05	0.000979	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—MYC—osteoporosis	7.06e-05	0.000969	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—TGFB1—osteoporosis	7.04e-05	0.000966	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.98e-05	0.000958	CbGpPWpGaD
Diflunisal—ALB—Metabolism—FDPS—osteoporosis	6.89e-05	0.000946	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PKM—osteoporosis	6.89e-05	0.000946	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—IL6—osteoporosis	6.83e-05	0.000938	CbGpPWpGaD
Diflunisal—PTGS2—Disease—LRP6—osteoporosis	6.82e-05	0.000936	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—TNF—osteoporosis	6.73e-05	0.000923	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—IL6—osteoporosis	6.71e-05	0.000921	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—TNF—osteoporosis	6.57e-05	0.000902	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—IDH2—osteoporosis	6.56e-05	0.0009	CbGpPWpGaD
Diflunisal—PTGS2—Disease—RPL24—osteoporosis	6.56e-05	0.000899	CbGpPWpGaD
Diflunisal—PTGS2—Disease—LTF—osteoporosis	6.56e-05	0.000899	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—FGB—osteoporosis	6.55e-05	0.000899	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PGLS—osteoporosis	6.53e-05	0.000897	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GPD2—osteoporosis	6.53e-05	0.000897	CbGpPWpGaD
Diflunisal—TTR—Disease—IRS1—osteoporosis	6.52e-05	0.000895	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CA2—osteoporosis	6.28e-05	0.000862	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—OXCT1—osteoporosis	6.28e-05	0.000862	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CYP27A1—osteoporosis	6.16e-05	0.000846	CbGpPWpGaD
Diflunisal—TTR—Disease—IL6R—osteoporosis	6.12e-05	0.00084	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—MGLL—osteoporosis	6.12e-05	0.00084	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ACP5—osteoporosis	6e-05	0.000823	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—ADCY5—osteoporosis	5.98e-05	0.00082	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ATIC—osteoporosis	5.98e-05	0.00082	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PNP—osteoporosis	5.98e-05	0.00082	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5.92e-05	0.000812	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—SPP1—osteoporosis	5.78e-05	0.000793	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.77e-05	0.000792	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	5.75e-05	0.000789	CbGpPWpGaD
Diflunisal—PTGS2—Disease—ACP5—osteoporosis	5.68e-05	0.00078	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—TPI1—osteoporosis	5.57e-05	0.000765	CbGpPWpGaD
Diflunisal—TTR—bone marrow—osteoporosis	5.56e-05	0.0812	CbGeAlD
Diflunisal—ALB—Selenium Micronutrient Network—IL6—osteoporosis	5.43e-05	0.000745	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—IL6—osteoporosis	5.31e-05	0.000728	CbGpPWpGaD
Diflunisal—PTGS2—Disease—TPI1—osteoporosis	5.28e-05	0.000725	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—P4HB—osteoporosis	5.24e-05	0.000719	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IRS2—osteoporosis	5.23e-05	0.000718	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—IDH2—osteoporosis	5.2e-05	0.000714	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GAPDH—osteoporosis	5.14e-05	0.000706	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—LEP—osteoporosis	5.12e-05	0.000702	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CA2—osteoporosis	5.08e-05	0.000697	CbGpPWpGaD
Diflunisal—ALB—Metabolism—OXCT1—osteoporosis	5.08e-05	0.000697	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—RAP1A—osteoporosis	5.01e-05	0.000687	CbGpPWpGaD
Diflunisal—PTGS2—Disease—P4HB—osteoporosis	4.97e-05	0.000682	CbGpPWpGaD
Diflunisal—ALB—Metabolism—MGLL—osteoporosis	4.95e-05	0.000679	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CYP27A1—osteoporosis	4.89e-05	0.000671	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—ESR1—osteoporosis	4.89e-05	0.00067	CbGpPWpGaD
Diflunisal—PTGS2—Disease—GAPDH—osteoporosis	4.88e-05	0.000669	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	4.8e-05	0.000659	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	4.79e-05	0.000657	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ACP5—osteoporosis	4.76e-05	0.000653	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.7e-05	0.000645	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.67e-05	0.000641	CbGpPWpGaD
Diflunisal—PTGS2—Disease—NFATC1—osteoporosis	4.63e-05	0.000636	CbGpPWpGaD
Diflunisal—PTGS2—Disease—DKK1—osteoporosis	4.6e-05	0.000631	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IRS1—osteoporosis	4.57e-05	0.000626	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	4.47e-05	0.000614	CbGpPWpGaD
Diflunisal—PTGS2—Disease—WNT1—osteoporosis	4.43e-05	0.000608	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—TPI1—osteoporosis	4.43e-05	0.000607	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—POMC—osteoporosis	4.4e-05	0.000603	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.37e-05	0.0006	CbGpPWpGaD
Diflunisal—PTGS2—Disease—FGA—osteoporosis	4.31e-05	0.000591	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IL6R—osteoporosis	4.29e-05	0.000588	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IGF1—osteoporosis	4.23e-05	0.00058	CbGpPWpGaD
Diflunisal—ALB—Metabolism—IDH2—osteoporosis	4.21e-05	0.000578	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—P4HB—osteoporosis	4.16e-05	0.000571	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GAPDH—osteoporosis	4.08e-05	0.00056	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ENO1—osteoporosis	4.05e-05	0.000556	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PSMA2—osteoporosis	3.99e-05	0.000548	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PSMA5—osteoporosis	3.99e-05	0.000548	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—RAP1A—osteoporosis	3.98e-05	0.000546	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYP27A1—osteoporosis	3.96e-05	0.000543	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ACP5—osteoporosis	3.85e-05	0.000528	CbGpPWpGaD
Diflunisal—PTGS2—Disease—ENO1—osteoporosis	3.84e-05	0.000527	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.8e-05	0.000522	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PSMA2—osteoporosis	3.78e-05	0.000519	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PSMA5—osteoporosis	3.78e-05	0.000519	CbGpPWpGaD
Diflunisal—TTR—Disease—MYC—osteoporosis	3.63e-05	0.000498	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.63e-05	0.000498	CbGpPWpGaD
Diflunisal—TTR—Disease—TGFB1—osteoporosis	3.62e-05	0.000497	CbGpPWpGaD
Diflunisal—ALB—Metabolism—TPI1—osteoporosis	3.58e-05	0.000491	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CALCA—osteoporosis	3.53e-05	0.000484	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.47e-05	0.000476	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	3.45e-05	0.000473	CbGpPWpGaD
Diflunisal—ALB—Metabolism—P4HB—osteoporosis	3.37e-05	0.000462	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GAPDH—osteoporosis	3.3e-05	0.000453	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CYP19A1—osteoporosis	3.24e-05	0.000444	CbGpPWpGaD
Diflunisal—ALB—Metabolism—RAP1A—osteoporosis	3.22e-05	0.000442	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ENO1—osteoporosis	3.22e-05	0.000441	CbGpPWpGaD
Diflunisal—PTGS2—Disease—KL—osteoporosis	3.2e-05	0.000439	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PSMA2—osteoporosis	3.17e-05	0.000435	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PSMA5—osteoporosis	3.17e-05	0.000435	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—IGF1—osteoporosis	2.96e-05	0.000407	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.81e-05	0.000385	CbGpPWpGaD
Diflunisal—TTR—Disease—IL6—osteoporosis	2.73e-05	0.000374	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ADCY5—osteoporosis	2.65e-05	0.000363	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GPX1—osteoporosis	2.64e-05	0.000362	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ENO1—osteoporosis	2.6e-05	0.000357	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CYP19A1—osteoporosis	2.57e-05	0.000353	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PSMA2—osteoporosis	2.56e-05	0.000352	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PSMA5—osteoporosis	2.56e-05	0.000352	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MYC—osteoporosis	2.54e-05	0.000349	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TGFB1—osteoporosis	2.54e-05	0.000348	CbGpPWpGaD
Diflunisal—PTGS2—Disease—ADCY5—osteoporosis	2.51e-05	0.000344	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—MTHFR—osteoporosis	2.43e-05	0.000334	CbGpPWpGaD
Diflunisal—PTGS1—uterus—osteoporosis	2.38e-05	0.0348	CbGeAlD
Diflunisal—PTGS2—Disease—MTHFR—osteoporosis	2.31e-05	0.000316	CbGpPWpGaD
Diflunisal—PTGS2—uterus—osteoporosis	2.28e-05	0.0333	CbGeAlD
Diflunisal—PTGS2—Disease—IRS2—osteoporosis	2.19e-05	0.000301	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ADCY5—osteoporosis	2.1e-05	0.000288	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GPX1—osteoporosis	2.09e-05	0.000287	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYP19A1—osteoporosis	2.08e-05	0.000285	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—POMC—osteoporosis	1.95e-05	0.000267	CbGpPWpGaD
Diflunisal—PTGS2—bone marrow—osteoporosis	1.93e-05	0.0282	CbGeAlD
Diflunisal—PTGS2—Metabolism—MTHFR—osteoporosis	1.93e-05	0.000265	CbGpPWpGaD
Diflunisal—PTGS2—Disease—IRS1—osteoporosis	1.92e-05	0.000263	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IL6—osteoporosis	1.91e-05	0.000262	CbGpPWpGaD
Diflunisal—PTGS2—Disease—IL6R—osteoporosis	1.8e-05	0.000247	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—TGFB1—osteoporosis	1.78e-05	0.000244	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ADCY5—osteoporosis	1.7e-05	0.000233	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GPX1—osteoporosis	1.69e-05	0.000232	CbGpPWpGaD
Diflunisal—ALB—Metabolism—MTHFR—osteoporosis	1.56e-05	0.000214	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—POMC—osteoporosis	1.54e-05	0.000212	CbGpPWpGaD
Diflunisal—ALB—Metabolism—POMC—osteoporosis	1.25e-05	0.000171	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MYC—osteoporosis	1.07e-05	0.000146	CbGpPWpGaD
Diflunisal—PTGS2—Disease—TGFB1—osteoporosis	1.06e-05	0.000146	CbGpPWpGaD
Diflunisal—PTGS2—Disease—IL6—osteoporosis	8.02e-06	0.00011	CbGpPWpGaD
